Spirometry is a poor predictor of asthma severity

R. L. Cowie, M. F. Underwood, S. K. Field (Calgary, Canada)

Source: Annual Congress 2002 - New aspects of asthma epidemiology
Session: New aspects of asthma epidemiology
Session type: Oral Presentation
Number: 165
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Spirometry, use of inhaled corticosteroid (ICS) and disease control have been used to assess asthma severity. In this study, asthma control was defined as no severe exacerbations, no night wakening, no time off work/school and by infrequent use of short-acting [betaagonists. We studied 500 consecutive patients attending an asthma clinic to examine the relevance of the percentage predicted forced expiratory volume in 1 sec (FEV1%) and forced expiratory ratio (FER) in determining asthma severity. The use and dose of ICS, presence of disease control and their assessment of lifestyle restriction by their disease were recorded. We found no relation between measurement of airway obstruction and the other indices of severity. FER was 0.72 and 0.72 (p= .9) and FEV1% 83 and 80 (p= .3) in those with and without disease control respectively. The daily dose of ICS did not differ in relationship to spirometry (p = .5). The dose of ICS was higher in those with poor disease control (beclomethasone equivalent 660μg/day versus 350μg/day) (p <.000001). Overall the use and dose of ICS was the strongest predictor of severity with disease control in 36%, 23%, 14% and 5% of those using ICS 0μg/day, 1-500μg/day, 501-1000μg/day and >1000μg/day respectively (p=.000002). The patients' perception of the restriction of their lifestyle by their asthma also correlated with their use and dose of ICS (p=.005) but not with the degree of airway obstruction (p = .6). We conclude that spirometric measurements of airway obstruction do not correlate with other indices of asthma severity. The use and dose of ICS best predict disease severity with poorest control and more lifestyle restriction in those on the highest doses of ICS.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. L. Cowie, M. F. Underwood, S. K. Field (Calgary, Canada). Spirometry is a poor predictor of asthma severity. Eur Respir J 2002; 20: Suppl. 38, 165

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can poor compliance be a predictor of asthma exacerbations severity in Ukrainian patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 687s
Year: 2006

Can asthma severity be a predictor of exacerbation severity?
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003

Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013

Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013

Assessment of predictive factors for asthma exacerbations severity
Source: Eur Respir J 2006; 28: Suppl. 50, 503s
Year: 2006

Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Factors associated with poor prognostic outcome in acute exacerbation of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009


Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010


Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Five FEV1 adjustment methods for grading airway obstruction severity in USA Caucasian patients
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015


Multimorbidity medications and poor asthma prognosis
Source: Eur Respir J, 51 (4) 1702114; 10.1183/13993003.02114-2017
Year: 2018



Hyalyronic acid as predictor of occupational COPD exacerbation
Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases
Year: 2021


Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 520s
Year: 2004

Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Correlation of various parameters with FEV1 in the assessment of asthma severity
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Risk factors for asthma exacerbations: is severity a predictor?
Source: Annual Congress 2003 - Burden of asthma
Year: 2003


Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020